Search

everythinglearnresearchcommunity

for

Search:↓

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

The test product significantly improved hair growth and reduced hair fall without causing skin issues.

TA-Ado effectively promotes hair growth and reduces hair loss.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

ADEM is a sudden brain disorder often following infection or vaccination, diagnosed by ruling out other conditions.

ATP helps prevent skin damage from vandetanib by reducing stress.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Adiantum capillus extract reduces pain and swelling in animals.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Upadacitinib effectively treats severe alopecia areata and is safe.

Adenosine treatment thickens hair in Caucasian men with hair loss.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

A woman lost all her hair in one day, was diagnosed with a rare type of hair loss, and regrew it in 12 weeks with treatment.

Microemulsions improve adapalene's skin absorption for better acne treatment.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Upadacitinib may cause hair loss.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Tazarotene gel may be more effective for acne than adapalene gel.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.